Monitoring STAAR Surgical Company (STAA) after recent insider movements


STAAR Surgical Company’s recent filing unveils that its Sr. VP, Comm. Ops., NA, APAC Francese James E unloaded Company’s shares for reported $2.66 million on Sep 27. In the deal valued at $75.00 per share,35,425 shares were sold. As a result of this transaction, Francese James E now holds 34,908 shares worth roughly $ 2.12 million.

Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report


Then, Holliday Keith sold 16,582 shares, generating $1,762,498 in total proceeds. Upon selling the shares at $106.29, the Chief Technology Officer now owns 19,437 shares.

Before that, Mason Caren L sold 35,000 shares. STAAR Surgical Company shares valued at $2,046,800 were divested by the President & CEO at a price of $58.48 per share. As a result of the transaction, Mason Caren L now holds 83,645 shares, worth roughly $5.09 million.

PT values the company’s stock at a premium of 33.13 to its Friday closing price. A number of analysts have revised their coverage, including Mizuho’s analysts, who began to cover the stock in mid October with a ‘”a Buy”‘ rating. Needham began covering STAA with “Buy” recommendation on April 08, 2022. The Benchmark Company revised its rating on March 28, 2022. It rated STAA as “a Buy” which previously was an “a Hold”.

Price Performance Review of STAA

On Friday, STAAR Surgical Company [NASDAQ:STAA] saw its stock jump 1.69% to $60.85. On the same session, the stock had its day’s lowest price of $60.00, but rose to a high of $62.65. Over the last five days, the stock has lost -14.50%. STAAR Surgical Company shares have fallen nearly -33.35% since the year began. Nevertheless, the stocks have fallen -48.04% over the past one year. While a 52-week high of $120.50 was reached on 08/12/22, a 52-week low of $49.03 was recorded on 05/12/22. SMA at 50 days reached $78.31, while 200 days put it at $74.05. A total of 0.68 million shares were traded, compared to the trading of 0.67 million shares in the previous session.

Levels Of Support And Resistance For STAA Stock

The 24-hour chart illustrates a support level at 59.68, which if violated will result in even more drops to 58.52. On the upside, there is a resistance level at 62.33. A further resistance level may holdings at 63.82. The Relative Strength Index (RSI) on the 14-day chart is 33.00, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -5.80, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 85.15%. Stochastics %K at 20.50% indicates the stock is a holding.

How much short interest is there in STAAR Surgical Company?

A steep rise in short interest was recorded in STAAR Surgical Company stocks on Jul 14, 2022, dropping by -0.4 million shares to a total of 2.93 million shares. Yahoo Finance data shows the prior-month short interest on Jun 14, 2022 was 3.33 million shares. There was a decline of -13.65%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 12.85% of the overall stock float, the days-to-cover ratio (short ratio) fell to 6.82.

STAAR Surgical Company [STAA] – Who Are The Largest Shareholders?

In filings from Broadwood Capital, Inc., it is revealed that the company now owns 8,592,007 shares, or roughly 17.89% of the outstanding STAA shares. Additionally, Baillie Gifford & Co. decreased -2.98% of its stake after which the total value it holdings stand at $361,766,502, while BlackRock Fund Advisors added 0.09% of its stake to hold $356.41 million in the firm. Over the last quarter, The Vanguard Group, Inc. purchased 71,730 shares of STAAR Surgical Company, while SSgA Funds Management, Inc. bought -12,892 shares. At present, Palo Alto Investors LP is holding 1,106,567 shares valued at $78.07 million. Geneva Capital Management LLC owned 947,126 shares of the company at the time of its most recent 13F filing, worth $66.82 million.

According to FactSet, STAAR Surgical Company’s share price will average $86.63 in the next year, based on opinions of analysts polled by the firm. This is up nearly 40.37 percent from its previous closing price of $59.84. Analysts expect STAAR Surgical Company stock to reach the higher price of $105.00, while the lowest price estimate is $78.00. However, 10 analysts have rated STAA stock as a Buy in their predictions for 2022.


Please enter your comment!
Please enter your name here